Drug combo may extend the lives of women with advanced endometrial cancer
A
combination of chemo plus Keytruda, an immunotherapy, extended
progression-free survival in women with advanced endometrial cancer. |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.